Literature DB >> 6184400

Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen.

M Peters, A S Fauci.   

Abstract

The in vitro effect of nonspecific factors (derived from mixed lymphocyte culture [MLC] supernatants) on human B cell responses was studied in individuals recently immunized in vivo to keyhole limpet hemocyanin, tetanus toxoid, and/or diphtheria toxin. In T cell-depleted fractions of peripheral blood mononuclear cells, nonspecific factors alone, without antigen, selectively induced a specific antibody response to the antigen to which the individual had been recently immunized, at dilutions that did not generate a significant polyclonal response in the remainder of the B cell repertoire. The source of these factors, with respect to MLC donors, did not affect the antibody response. Supernatants of MLC from nonimmunized individuals induced a specific antibody response as effectively as supernatants of MLC from immunized individuals, when added to B cells plus monocytes from recently immunized individuals. Studies in which the same individuals were followed over time showed that these factor-sensitive B cells are seen in the peripheral blood of recently immunized individuals for only a finite period of time. Thus, in vivo immunization with a specific antigen results in the transient appearance in the peripheral blood of B cells that are specific for the antigen in question. These B cells are probably preactivated in that nonspecific factors selectively induce in vitro their further differentiation into antibody-secreting cells, in the absence of added antigen or mitogen. These studies may add further insight into our understanding of the sequential steps involved in the activation and differentiation of human B lymphocytes and provide a model for the combined in vivo and in vitro study of human B cell physiology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6184400

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood.

Authors:  M G Peters; H Secrist; K R Anders; G S Nash; S R Rich; R P MacDermott
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

2.  Mitogenic stimulation of malignant B cells Waldenstrøm's macroglobulinaemia: secretion of monoclonal IgM by in vitro-induced plasmablasts.

Authors:  A C Bloem; M A Chand; B van Camp; E J Bast; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

3.  Antibody synthesis specific for nonoral antigens in inflamed gingiva.

Authors:  S M Mallison; A K Szakal; R R Ranney; J G Tew
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

5.  In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; M Levrero; G Ruberti; A van Dyke; A Perrone; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

6.  Modulation of human B cell responses by a monoclonal antibody to an activation antigen 4F2.

Authors:  T L Gerrard; C H Jurgensen; A S Fauci
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

7.  Regulation of human B-cell activation, proliferation, and differentiation by soluble factors.

Authors:  A Muraguchi; J H Kehrl; J L Butler; A S Fauci
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

8.  Non-specific factor enhancement of human in vitro antigen-dependent antibody synthesis: role of B cell activation and T cell help.

Authors:  M K Brenner; M E North; H R Chadda; J Farrant
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

9.  Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.

Authors:  N Lycke; L Lindholm; J Holmgren
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

10.  Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation.

Authors:  S M Mallison; J P Smith; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.